FOCUS on FOCIS: combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer.
Rozková D, Tiserová H, Fucíková J, Last'ovicka J, Podrazil M, Ulcová H, Budínský V, Prausová J, Linke Z, Minárik I, Sedivá A, Spísek R, Bartůnková J.
Rozková D, et al. Among authors: bartunkova j.
Clin Immunol. 2009 Apr;131(1):1-10. doi: 10.1016/j.clim.2009.01.001. Epub 2009 Feb 8.
Clin Immunol. 2009.
PMID: 19201656
Review.